A meta-analysis has identified a significantly increased risk of serious adverse events and treatment discontinuation in patients receiving telaprevir

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1419, 2012-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Proton Pump Inhibitors on Adverse Gastrointestinal Events in Patients Receiving Clopidogrel: Systematic Review and Meta-Analysis

By >   >   >  

Drug Safety, Vol. 34, Iss. 1, 2011-01 ,pp. : 47-57

Adis International

Access to resources Recommend Favorite

Comparison of the Risk of Adverse Events with Pramipexole and Ropinirole in Patients with Parkinson’s Disease: A Meta-Analysis

By Etminan M.  

Drug Safety, Vol. 26, Iss. 6, 2003-01 ,pp. : 439-444

Adis International

Access to resources Recommend Favorite

Non-compliance and discontinuation increases the risk of cardiovascular events in patients receiving low-dose aspirin

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 11, 2010-11 ,pp. : 24-26

Adis International

Access to resources Recommend Favorite

Thiazolidinedione treatment is not associated with an increased risk of major adverse cardiovascular events

By  

Inpharma, Vol. 1, Iss. 1643, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Increased Risk of Somnolence with the New Dopamine Agonists in Patients with Parkinson's Disease: A Meta-Analysis of Randomised Controlled Trials

By Etminan M.  

Drug Safety, Vol. 24, Iss. 11, 2001-01 ,pp. : 863-868

Adis International

Access to resources Recommend Favorite